Cargando…

Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence

Hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant disease, is characterized by telangiectases and arteriovenous malformations (AVMs). Untreated AVMs, especially in the lungs—pulmonary AVMs (PAVMs)—can result in morbidity with a decreased life expectancy. We have investigated whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Gussem, Els M., Kroon, Steven, Hosman, Anna E., Kelder, Johannes C., Post, Martijn C., Snijder, Repke J., Mager, Johannes J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694763/ https://www.ncbi.nlm.nih.gov/pubmed/33172103 http://dx.doi.org/10.3390/jcm9113581

Ejemplares similares

Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology
por: Bofarid, Sala, et al.
Publicado: (2021)

Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence
por: Kilian, Alexandra, et al.
Publicado: (2020)

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
por: Zarrabeitia, Roberto, et al.
Publicado: (2017)

A case report of hepatopulmonary syndrome in hereditary hemorrhagic telangiectasia (HHT): Not all right-to-left shunting in HHT is due to pulmonary arteriovenous malformations
por: Krishnan, Sheila, et al.
Publicado: (2018)

Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
por: Lee, John M., et al.
Publicado: (2019)

Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients
por: Guilhem, Alexandre, et al.
Publicado: (2017)

Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation
por: Joyce, Katie E., et al.
Publicado: (2022)

Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
por: Gaetani, Eleonora, et al.
Publicado: (2020)

Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

Pulmonary Arterial Hypertension and Hereditary Haemorrhagic Telangiectasia
por: Vorselaars, Veronique M. M., et al.
Publicado: (2018)

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)
por: Shovlin, Claire L., et al.
Publicado: (2018)

Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT
por: Le, Thi Thao Truc, et al.
Publicado: (2022)

Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia
por: de Gussem, E. M., et al.
Publicado: (2016)

Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial
por: Mei-Zahav, Meir, et al.
Publicado: (2020)

Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study
por: Hessels, Josefien, et al.
Publicado: (2022)

European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)
por: Eker, Omer F., et al.
Publicado: (2020)

Endoglin involvement in integrin-mediated cell adhesion as a putative pathogenic mechanism in hereditary hemorrhagic telangiectasia type 1 (HHT1)
por: Rossi, Elisa, et al.
Publicado: (2015)

Genotype–Phenotype Correlations in Children with HHT
por: Kilian, Alexandra, et al.
Publicado: (2020)

Mononuclear cells and vascular repair in HHT
por: Dingenouts, Calinda K. E., et al.
Publicado: (2015)

TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)—A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial
por: Andorfer, Kornelia E. C., et al.
Publicado: (2022)

Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
por: Marcos, Sol, et al.
Publicado: (2021)

Clinical and genetic challenges in a family with history of childhood polyp, aortopathy, and clinical diagnosis of hereditary hemorrhagic teleangiectasia (HHT)
por: Kadiyska, Tanya, et al.
Publicado: (2016)

Time heals all wounds—but 12-HHT is faster
por: Gus-Brautbar, Yael, et al.
Publicado: (2014)

Classification of endonasal HHT lesions using digital microscopy
por: Haubner, F., et al.
Publicado: (2021)

Incidence of Spontaneous Pulmonary AVM Rupture in HHT Patients
por: Fish, Adam, et al.
Publicado: (2021)

Improved HHT-microstate analysis of EEG in nicotine addicts
por: Xiong, Xin, et al.
Publicado: (2023)

Fine mapping of the hereditary haemorrhagic telangiectasia (HHT)3 locus on chromosome 5 excludes VE-Cadherin-2, Sprouty4 and other interval genes
por: Govani, Fatima S, et al.
Publicado: (2010)

Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14
por: Letteboer, Tom G. W., et al.
Publicado: (2015)

Individualized therapy of HHT driven by network analysis of metabolomic profiles
por: Jamshidi, Neema, et al.
Publicado: (2011)

Early detection of myocardial ischemia in resting ECG: analysis by HHT
por: Wang, Chun-Lin, et al.
Publicado: (2023)

Executive summary of the 14th HHT international scientific conference
por: Ola, Roxana, et al.
Publicado: (2023)

Tacrolimus in Gastrointestinal Bleeding in a Young Boy With Hereditary Hemorrhagic Telangiectasia
por: Pruijsen, Jessica M., et al.
Publicado: (2021)

Long-term efficacy assessment of current treatment options for epistaxis in HHT
por: Dür, Cilgia, et al.
Publicado: (2021)

Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia
por: Vorselaars, V. M. M., et al.
Publicado: (2018)

Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation and Hereditary Hemorrhagic Telangiectasia
por: Velthuis, Sebastiaan, et al.
Publicado: (2012)

Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT
por: Kilian, Alexandra, et al.
Publicado: (2023)

HHT diagnosis by Mid-infrared spectroscopy and artificial neural network analysis
por: Lux, Andreas, et al.
Publicado: (2013)

Structure of the agonist 12–HHT in its BLT2 receptor-bound state
por: Giusti, Fabrice, et al.
Publicado: (2020)

Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance
por: Li, Fenglin, et al.
Publicado: (2022)

Vascular defects associated with hereditary hemorrhagic telangiectasia revealed in patient-derived isogenic iPSCs in 3D vessels on chip
por: Orlova, Valeria V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vuit5ndo2hgff9co1evaon45gi